“FDA inspectors inspect for compliance; EU inspectors inspect for adequate science”.
歐洲強調的重點:
ØThe expectations of Quality Management and the role of the QP
ØThe expectation for, and extensiveness of, validation
ØThe need for self-inspection (=internal audits)
ØTraining and assessment of competence
ØThe role of contract manufacture and analysis
沒有留言:
張貼留言